Clinical investigation of fertility after uterine artery embolization combined with dilation and curettage(D&C) or D&C alone for cesarean scar pregnancies
- PMID: 40206394
- PMCID: PMC11979471
- DOI: 10.1016/j.eurox.2025.100379
Clinical investigation of fertility after uterine artery embolization combined with dilation and curettage(D&C) or D&C alone for cesarean scar pregnancies
Abstract
Objective: The aim of this study was to compare the reproductive outcomes of patients with cesarean scar pregnancies (CSP) following uterine artery embolization (UAE) and dilation and curettage (D&C) treatments, and to evaluate the impact of UAE on fertility.
Materials: and methods: A retrospective case-control study was conducted. Patients diagnosed with CSP between 2019 and 2021 were included in the study. Clinical data and fertility outcomes were collected and reviewed retrospectively. Patients were divided into two groups based on their treatment option: the UAE combined with D&C group and the D&C alone group.
Results: A total of 91 CSP patients were enrolled in the study. Of these, 49 were treated with D&C, while 42 received UAE combined with D&C. The average gestational age in the UAE group was significantly longer than that in the D&C group. The average diameter of the gestational mass was significantly larger in the UAE group than in the D&C group (42.2 ± 19.8 mm vs 23.8 ± 15.9 mm). The other clinical features were not significantly different between the two groups. The average menstrual recovery time was 1.0 ± 0.20 months (range: 1-2 months) in the D&C group, and 2.0 ± 2.85 months (range: 1-18 months) in the UAE combined with D&C group, with a significant difference between the two groups. The average menstrual blood volume (MBV) decreased in 79 % of patients in the UAE group, compared to 18 % in the D&C group, with a significant difference between the two groups. There was no significant difference between the two groups in terms of pregnancy rate and birth rate (75 % vs 78 %, 63 % vs 56 %).
Conclusion: UAE combined with D&C is an efficient and safe treatment for CSP. Our study showed that decreased MBV and longer menstrual recovery time in UAE combined with D&C group, but there are no statistical difference in fertility outcomes between the two groups, which suggests probably a reversible impact on the reproductive function.
Keywords: Dilation and curettage; Fertility; Uterine artery embolisation.
© 2025 The Authors.
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this article.
Similar articles
-
Reproductive outcomes of cesarean scar pregnancies treated with uterine artery embolization combined with curettage.Taiwan J Obstet Gynecol. 2022 Jul;61(4):601-605. doi: 10.1016/j.tjog.2021.08.005. Taiwan J Obstet Gynecol. 2022. PMID: 35779907
-
Clinical efficacy and re-pregnancy outcomes of patients with previous cesarean scar pregnancy treated with either high-intensity focused ultrasound or uterine artery embolization before ultrasound-guided dilatation and curettage: a retrospective cohort study.BMC Pregnancy Childbirth. 2023 Feb 1;23(1):85. doi: 10.1186/s12884-023-05376-0. BMC Pregnancy Childbirth. 2023. PMID: 36726079 Free PMC article.
-
Association of menstrual blood volume and reproductive outcomes in patients with caesarean scar pregnancy managed using uterine artery embolization and curettage.Hum Fertil (Camb). 2023 Dec;26(6):1491-1496. doi: 10.1080/14647273.2023.2207746. Epub 2023 May 8. Hum Fertil (Camb). 2023. PMID: 37154620
-
Interventions for non-tubal ectopic pregnancy.Cochrane Database Syst Rev. 2020 Jul 1;7(7):CD011174. doi: 10.1002/14651858.CD011174.pub2. Cochrane Database Syst Rev. 2020. PMID: 32609376 Free PMC article.
-
Uterine artery embolization combined with methotrexate in the treatment of cesarean scar pregnancy: results of a case series and review of the literature.J Vasc Interv Radiol. 2012 Dec;23(12):1582-8. doi: 10.1016/j.jvir.2012.08.013. J Vasc Interv Radiol. 2012. PMID: 23177105 Review.
References
-
- Timor-Tritsch I.E., Monteagudo A., Cali G., D'Antonio F., Kaelin Agten A. Cesarean scar pregnancy: diagnosis and pathogenesis. Obstet Gynecol Clin North Am. 2019;46(4):797–811. - PubMed
-
- Bick D., National Collaborating Centre for Ws. Children's H, National Institute for Clinical E Caesarean Section. Clinical Guideline. National Collaborating Centre for Women's and Children's Health: commissioned by the National Institute for Clinical Excellence. World Evid Based Nurs. 2004;1(3):198–199. - PubMed
-
- Maheux-Lacroix S., Li F., Bujold E., Nesbitt-Hawes E., Deans R., Abbott J. Cesarean scar pregnancies: a systematic review of treatment options. J Minim Invasive Gynecol. 2017;24(6):915–925. - PubMed
-
- Wang J., Wang D., Zhang X., Liu Y., Yang Q., Zhang N. The effect of prophylactic uterine artery embolization on reproductive outcomes in patients with cesarean scar pregnancy: a propensity score-matched study. Arch Gynecol Obstet. 2022;305(3):651–659. - PubMed
LinkOut - more resources
Full Text Sources